195 related articles for article (PubMed ID: 19350235)
1. Positron emission tomography in patients suffering from HIV-1 infection.
Sathekge M; Goethals I; Maes A; van de Wiele C
Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1176-84. PubMed ID: 19350235
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET imaging in HIV infection and tuberculosis.
Sathekge M; Maes A; Van de Wiele C
Semin Nucl Med; 2013 Sep; 43(5):349-66. PubMed ID: 23905617
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET.
Sathekge M; Maes A; Kgomo M; Stolz A; Ankrah A; Van de Wiele C
Nucl Med Commun; 2010 Apr; 31(4):311-4. PubMed ID: 20145581
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables.
Lucignani G; Orunesu E; Cesari M; Marzo K; Pacei M; Bechi G; Gori A; Gaito S; Clerici M; Chiti A
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):640-7. PubMed ID: 19082590
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism.
Georgiou MF; Gonenc A; Waldrop-Valverde D; Kuker RA; Ezuddin SH; Sfakianakis GN; Kumar M
J Nucl Med; 2008 Dec; 49(12):1999-2005. PubMed ID: 18997046
[TBL] [Abstract][Full Text] [Related]
6. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
[TBL] [Abstract][Full Text] [Related]
7. Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT.
Liu Y
Ann Nucl Med; 2011 Oct; 25(8):536-46. PubMed ID: 21674240
[TBL] [Abstract][Full Text] [Related]
8. Whole-body positron emission tomography in patients with HIV-1 infection.
Scharko AM; Perlman SB; Pyzalski RW; Graziano FM; Sosman J; Pauza CD
Lancet; 2003 Sep; 362(9388):959-61. PubMed ID: 14511930
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.
Wiley CA; Lopresti BJ; Becker JT; Boada F; Lopez OL; Mellors J; Meltzer CC; Wisniewski SR; Mathis CA
J Neurovirol; 2006 Aug; 12(4):262-71. PubMed ID: 16966217
[TBL] [Abstract][Full Text] [Related]
10. High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease.
Belkhir L; Jonckheere S; Lhommel R; Vandercam B; Yombi JC
Acta Clin Belg; 2011; 66(6):419-21. PubMed ID: 22338303
[TBL] [Abstract][Full Text] [Related]
11. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD
Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography in the prediction of inflammation in children with human immunodeficiency virus related bronchiectasis.
Masekela R; Gongxeka H; Green RJ; Sathekge M
Hell J Nucl Med; 2012; 15(1):23-7. PubMed ID: 22413108
[TBL] [Abstract][Full Text] [Related]
13. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT in patients with HIV.
Davison JM; Subramaniam RM; Surasi DS; Cooley T; Mercier G; Peller PJ
AJR Am J Roentgenol; 2011 Aug; 197(2):284-94. PubMed ID: 21785073
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
[TBL] [Abstract][Full Text] [Related]
17. The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CT.
Mankia SK; Miller RF; Edwards SG; Ramsay A; Lee SM
Clin Nucl Med; 2012 Jul; 37(7):692-3. PubMed ID: 22691516
[TBL] [Abstract][Full Text] [Related]
18. Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma.
Kung BT; Mak WS; Lau SM; Auyong TK; Tong CM
World J Nucl Med; 2015; 14(1):53-6. PubMed ID: 25709547
[TBL] [Abstract][Full Text] [Related]
19. Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals.
Hammoud DA; Sinharay S; Steinbach S; Wakim PG; Geannopoulos K; Traino K; Dey AK; Tramont E; Rapoport SI; Snow J; Mehta NN; Smith BR; Nath A
Neurology; 2018 Oct; 91(17):e1591-e1601. PubMed ID: 30258017
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.
Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N
BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
